Pfizer Q2 PAT seen up 8.4% to Rs 78.3 cr: Centrum

Net Sales are expected to increase by 8.1 percent Q-o-Q (up 5.8 percent Y-o-Y) to Rs 542 crore, according to Centrum.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney IThe Winning Leap SME Special
Moneycontrol

Home » News » Earnings » Brokerage Results Estimates

Oct 19, 2016, 03.56 PM | Source: Moneycontrol.com

Pfizer Q2 PAT seen up 8.4% to Rs 78.3 cr: Centrum

Net Sales are expected to increase by 8.1 percent Q-o-Q (up 5.8 percent Y-o-Y) to Rs 542 crore, according to Centrum.

Like this story, share it with millions of investors on M3

Pfizer Q2 PAT seen up 8.4% to Rs 78.3 cr: Centrum

Net Sales are expected to increase by 8.1 percent Q-o-Q (up 5.8 percent Y-o-Y) to Rs 542 crore, according to Centrum.

Post Your Comments

Share Cancel

Centrum Broking (more)

, Centrum Broking |

Centrum has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Pfizer to report net profit at Rs 78.3 crore, up 8.4 percent quarter-on-quarter.

Net Sales are expected to increase by 8.1 percent Q-o-Q (up 5.8 percent Y-o-Y) to Rs 542 crore, according to Centrum.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 11.7 percent Q-o-Q (down 1.1 percent Y-o-Y) to Rs 113 crore.

Centrum's report on Pfizer

We expect Pfizer to report revenue growth of 6% YoY and 8% QoQ to Rs5.42bn. Pfizer’s flagship brands, namely, Minipress XL, Mucaine, Wysolone, Corex-Dx, Autrin and Prevenar 13 are likely to report double-digit growth during the quarter.

Pfizer is expected to report 42% YoY and 8% QoQ growth in net profit to Rs783mn from Rs553mn due to lower tax rate. We expect tax rate to decline to 34.9% from 45.1% of PBT.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click here

Tags  Pfizer Centrum
Buy, Hold, Sell ? Hear it first on M3
Pfizer Q2 PAT seen up 8.4% to Rs 78.3 cr: Centrum

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login